During the past decade, Express Scripts conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Express Scripts" #1 collaborator was "National Institute on Aging (NIA)" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Express Scripts" are "Conversion From Brand Name to Generic Medication" (1 trials) and "Preventative Health" (1 trials). Many other conditions were trialed in "Express Scripts" in a lesser frequency.

Most popular intervention types in "Express Scripts" are "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Scheduling and Active Choice for Biometric Participation" (1 trials) and "Social Proximity and Conversion to Generic Medications" (1 trials). Other intervention names were less common.

The vast majority of trials in "Express Scripts" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Express Scripts". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Express Scripts, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Express Scripts, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".